Proposal DM153184

Ended Definitive Contract Awarded Last action

Contract number
W81XWH16C0188
Awardee
Awarding agency
Obligated
$1,499,638

Award facts

Opportunity
Contract value 100% obligated
$1,499,637.87 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21205, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00005 · Research and development contract -$12
Change Order P00004 -$1,394,058
Supplemental Agreement for work within scope P00003 $0
Change Order P00002 $0
Change Order P00001 · Proposal DM153184 - r & d contract - tesamorelin therapy to enhance axonal regeneration, minimize muscle atrophy and improve functional outcomes following… $0
Original award $2,893,707

About this award

This is a research and development contract awarded by the Defense Health Agency to The Johns Hopkins University, a leading private research university. The contract has a ceiling value of $1,499,637.87 and a completion date of January 31, 2022. It is a definitive contract with cost-no-fee pricing.

The contract has two major subcontractors: Medstar Health Research Institute Inc., a non-profit healthcare research organization, and the University of Maryland, Baltimore, a prominent academic health sciences institution. These subcontractors provide specialized medical research services, laboratory support, and other related capabilities to the prime contractor.

While the original solicitation is not provided, the contract appears to cover a broad range of research and development activities across multiple scientific and medical domains, leveraging the expertise of the prime and subcontractor organizations. The contract does not have a set-aside designation, indicating open competition.

The Defense Health Agency, as part of the Department of Defense, is responsible for providing health services to the U.S. Armed Forces, their families, and other eligible beneficiaries. This contract supports the agency's broader research and development efforts in areas such as medical innovation, public health, and scientific discovery.

Quick answers

Who was awarded contract W81XWH16C0188?

W81XWH16C0188 was awarded to The Johns Hopkins University by Medical Command (Department of the Army) on September 30, 2016.

How much is contract W81XWH16C0188 worth?

The government has obligated $1,499,638 on W81XWH16C0188.

Which agency awarded contract W81XWH16C0188?

Medical Command (Department of the Army) awarded W81XWH16C0188, with funding from Defense Health Agency (Department of Defense).

Was contract W81XWH16C0188 competed?

The extent of competition for W81XWH16C0188 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award